{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:54:23Z","timestamp":1790996063119,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":288,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["TE 343\/4-1"],"award-info":[{"award-number":["TE 343\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["DFG\/SFB405"],"award-info":[{"award-number":["DFG\/SFB405"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wellcome Trust","award":["WT080782MF"],"award-info":[{"award-number":["WT080782MF"]}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"crossref","award":["2006\/R1"],"award-info":[{"award-number":["2006\/R1"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.neurobiolaging.2011.12.006","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T04:46:18Z","timestamp":1326170778000},"page":"2478-2490","source":"Crossref","is-referenced-by-count":75,"title":["Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity"],"prefix":"10.1016","volume":"33","author":[{"given":"Peter","family":"Teismann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinnari","family":"Sathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Bierhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bucala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Weigle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Nawroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg B.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/376167a0","article-title":"Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B","volume":"376","author":"Beg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neurobiolaging.2008.05.017","article-title":"S100B\/RAGE-dependent activation of microglia via NF-kappaB and AP-1 co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha","volume":"31","author":"Bianchi","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib3","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1172\/JCI18058","article-title":"Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily","volume":"114","author":"Bierhaus","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib4","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.2337\/diabetes.50.12.2792","article-title":"Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB","volume":"50","author":"Bierhaus","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib5","first-page":"1699","article-title":"Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues","volume":"143","author":"Brett","year":"1993","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2008.03.093","article-title":"Nuclear factor kappa-B mediates selective induction of neuronal nitric oxide synthase in astrocytes during low-level inflammatory stimulation with MPTP","volume":"1217","author":"Carbone","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/mol.108.050781","article-title":"Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nitric-oxide synthase 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosis","volume":"75","author":"Carbone","year":"2009","journal-title":"Mol. Pharmacol"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.jnen.0000179050.54522.5a","article-title":"Evidence of oxidative stress in the neocortex in incidental lewy body disease","volume":"64","author":"Dalf\u00f3","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","article-title":"Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation","volume":"88","author":"Dehmer","year":"2004","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib10","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1046\/j.1471-4159.2000.0742213.x","article-title":"Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo","volume":"74","author":"Dehmer","year":"2000","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0167-4889(99)00058-0","article-title":"Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type","volume":"1450","author":"Donato","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib12","series-title":"Merritt's neurology","first-page":"679","article-title":"Parkinsonism","year":"2000"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib13","doi-asserted-by":"crossref","first-page":"18754","DOI":"10.1073\/pnas.0704908104","article-title":"Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of parkinson's disease","volume":"104","author":"Ghosh","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib14","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s00702-006-0482-x","article-title":"Time dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice","volume":"113","author":"Himeda","year":"2006","journal-title":"J. Neural Transm"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib16","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.271.5.2543","article-title":"S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes","volume":"271","author":"Hu","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib17","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","article-title":"Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease","volume":"94","author":"Hunot","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib18","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999","article-title":"FcepsilonRII\/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells","volume":"19","author":"Hunot","year":"1999","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1073\/pnas.0307453101","article-title":"JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of parkinson's disease","volume":"101","author":"Hunot","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib20","doi-asserted-by":"crossref","first-page":"40096","DOI":"10.1074\/jbc.M006993200","article-title":"Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation","volume":"275","author":"Huttunen","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0076-6879(99)00141-X","article-title":"Nuclear factor kappa B activity in response to oxidants and antioxidants","volume":"300","author":"Janssen","year":"1999","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0167-4889(98)00144-X","article-title":"Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9)","volume":"1448","author":"Kerkhoff","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0197-4580(03)00126-X","article-title":"Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production","volume":"25","author":"Kim","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib24","doi-asserted-by":"crossref","first-page":"31740","DOI":"10.1074\/jbc.274.44.31740","article-title":"N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression","volume":"274","author":"Kislinger","year":"1999","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuroscience.2004.06.013","article-title":"S100B potently activates p65\/c-rel transcriptional complexes in hippocampal neurons: Clinical implications for the role of S100B in excitotoxic brain injury","volume":"127","author":"K\u00f6gel","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0197-0186(01)00047-X","article-title":"S100B proteins that lack one or both cysteine residues can induce inflammatory responses in astrocytes and microglia","volume":"39","author":"Koppal","year":"2001","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib27","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1471-4159.2000.0740143.x","article-title":"S100beta induction of the proinflammatory cytokine interleukin-6 in neurons","volume":"74","author":"Li","year":"2000","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib30","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib31","first-page":"55","article-title":"GDNF and NT-4 protect midbrain dopaminergic neurons from toxic damage by iron and nitric oxide","volume":"163","author":"Lingor","year":"2000","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib33","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1016\/S0021-9258(18)42741-X","article-title":"Immunochemical detection of advanced glycosylation end products in vivo","volume":"267","author":"Makita","year":"1992","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib34","doi-asserted-by":"crossref","first-page":"12023","DOI":"10.1523\/JNEUROSCI.2435-08.2008","article-title":"The HMGB1 receptor RAGE mediates ischemic brain damage","volume":"28","author":"Muhammad","year":"2008","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0891-0618(00)00096-X","article-title":"Crosslinking of alpha-synuclein by advanced glycation endproducts\u2014an early pathophysiological step in lewy body formation?","volume":"20","author":"M\u00fcnch","year":"2000","journal-title":"J. Chem. Neuroanat"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/glia.10225","article-title":"Expression of S-100 protein is related to neuronal damage in MPTP-treated mice","volume":"42","author":"Muramatsu","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0166-2236(96)01035-1","article-title":"NF-kappa B: A crucial transcription factor for glial and neuronal cell function","volume":"20","author":"O'Neill","year":"1997","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","article-title":"Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts","volume":"4","author":"Park","year":"1998","journal-title":"Nat. Med"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0006-8993(81)90843-X","article-title":"Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum","volume":"225","author":"Pickel","year":"1981","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib40","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): A technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib41","series-title":"Dopamine Receptors and Transporters","first-page":"363","article-title":"Dopaminergic system in parkinson's disease","year":"2002"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib42","first-page":"688","article-title":"Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease","volume":"146","author":"Ritthaler","year":"1995","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI200114002","article-title":"The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses","volume":"108","author":"Schmidt","year":"2001","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib44","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.0022-3042.2002.00796.x","article-title":"N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth","volume":"80","author":"Srikrishna","year":"2002","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib45","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0169-409X(02)00160-6","article-title":"Receptor for advanced glycation endproducts: A multiligand receptor magnifying cell stress in diverse pathologic settings","volume":"54","author":"Stern","year":"2002","journal-title":"Adv. Drug Deliv. Rev"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00441-004-0944-0","article-title":"Cellular pathology of parkinson's disease: Astrocytes, microglia and inflammation","volume":"318","author":"Teismann","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00001756-200104170-00037","article-title":"Nuclear factor-kappaB activation is not involved in a MPTP model of parkinson's disease","volume":"12","author":"Teismann","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib48","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0006-8993(74)90617-9","article-title":"5-hydroxydopamine \u201ctagged\u201d neuronal boutons in rabbit neostriatum: Interrelationship between vesicles and axonal membrane","volume":"82","author":"Tennyson","year":"1974","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ana.20133","article-title":"L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of parkinson's disease","volume":"56","author":"Tieu","year":"2004","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib51","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib52","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinson's disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2011.12.006_bib53","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458011005239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458011005239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T12:32:18Z","timestamp":1713357138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458011005239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0197458011005239"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.12.006","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}